(Q43056374)

13 November 2017

Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial (English)

1 reference

multicenter clinical trial

13 November 2017

0 references

1 reference

1 reference

Mahmoud Ahmad Abdel-Aleem

object named as

Mahmoud Ahmad Abdel-Aleem

12

0 references

G. Justus Hofmeyr

3

object named as

G Justus Hofmeyr

1 reference

13 November 2017

14

Beverly Winikoff

1 reference

13 November 2017

Mariana Widmer

1

1 reference

13 November 2017

Jennifer Blum

2

1 reference

13 November 2017

Guillermo Carroli

4

1 reference

13 November 2017

Hany Abdel-Aleem

5

1 reference

13 November 2017

Pisake Lumbiganon

6

1 reference

13 November 2017

Thi Nhu Ngoc Nguyen

7

1 reference

13 November 2017

Daniel Wojdyla

8

1 reference

13 November 2017

Jadsada Thinkhamrop

9

1 reference

13 November 2017

Mandisa Singata

10

1 reference

13 November 2017

Luciano E Mignini

11

1 reference

13 November 2017

Son Thach Tran

13

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

375

1 reference

13 November 2017

9728

1 reference

13 November 2017

1808-1813

1 reference

WHO analysis of causes of maternal death: a systematic review

13 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Primary postpartum haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Saving maternal lives in resource-poor settings: facing reality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol for preventing PPH: some lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Evaluation of postpartum blood loss after misoprostol-induced labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Treatment of postpartum hemorrhage with misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol for the prevention and treatment of postpartum haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol to treat postpartum haemorrhage: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Treatment for primary postpartum haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Pharmacokinetics of different routes of administration of misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Oral misoprostol for induction of labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Vaginal misoprostol for cervical ripening and induction of labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960348-0

7 January 2021

10.1016/S0140-6736(10)60348-0

Identifiers

DOI

1 reference

13 November 2017

1 reference